280. 巨大動静脈奇形(頚部顔面又は四肢病変) Huge arteriovenous malformation with cervicofacial or limb lesion Clinical trials / Disease details
臨床試験数 : 27 / 薬物数 : 30 - (DrugBank : 15) / 標的遺伝子数 : 14 - 標的パスウェイ数 : 153
Showing 1 to 10 of 27 diseases
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT05125471 (ClinicalTrials.gov) | July 26, 2022 | 12/11/2021 | Cobimetinib In Extracranial Arteriovenous Malformations (COBI-AVM Study) | COBI-AVM Study - Phase 2 Study to Assess the Safety and Efficacy of Cobimetinib In Extracranial Arteriovenous Malformations (AVM) COBI-AVM Study - Phase 2 Study to Assess the Safety and Efficacy of Cobimetinib In Extracranial Arte ... | Arteriovenous Malformations (Extracranial) | Drug: Cobimetinib | University of Arkansas | Genentech, Inc. | Recruiting | 2 Years | 80 Years | All | 17 | Phase 2 | United States |
2 | NCT04772963 (ClinicalTrials.gov) | February 2022 | 23/2/2021 | Genetics of Central Nervous System Arteriovenous Malformations (GENE-MAV) | Genetics of Central Nervous System Arteriovenous Malformations (AVM): Genotype-Phenotype Correlation and Prognostic Impact on Patients With AVM Genetics of Central Nervous System Arteriovenous Malformations (AVM): Genotype-Phenotype Correlation ... | Arteriovenous Malformations | Genetic: blood sample | Fondation Ophtalmologique Adolphe de Rothschild | NULL | Not yet recruiting | N/A | N/A | All | 300 | NULL | |
3 | ChiCTR2100048193 | 2021-07-01 | 2021-07-04 | Clinical study of bilateral uterine artery embolization versus surgical resection in the treatment of uterine arteriovenous malformation Clinical study of bilateral uterine artery embolization versus surgical resection in the treatment o ... | Clinical study of bilateral uterine artery embolization versus surgical resection in the treatment of uterine arteriovenous malformation Clinical study of bilateral uterine artery embolization versus surgical resection in the treatment o ... | Uterine arteriovenous malformation | Experimental group:Uterine arterial embolization;Control group:Surgical resection; | Henan Provincial People's Hospital | NULL | Pending | Female | Experimental group:10;Control group:10; | Phase 4 | China | ||
4 | NCT04297033 (ClinicalTrials.gov) | January 1, 2021 | 21/2/2020 | Lovastatin for Treatment of Brain Arteriovenous Malformations | Lovastatin for Treatment of Brain Arteriovenous Malformations:a Double-blind, Placebo-controlled Randomized Trial Lovastatin for Treatment of Brain Arteriovenous Malformations:a Double-blind, Placebo-controlled Ran ... | Cerebral Arteriovenous Malformation | Drug: Lovastatin;Drug: Placebo | Beijing Tiantan Hospital | NULL | Not yet recruiting | 18 Years | N/A | All | 1244 | Phase 2 | China |
5 | ChiCTR2000036597 | 2020-10-01 | 2020-08-24 | The safety and efficacy of embolization of jaw arteriovenous malformations: one center observational study The safety and efficacy of embolization of jaw arteriovenous malformations: one center observational ... | The safety and efficacy of embolization of jaw arteriovenous malformations: one center observational study The safety and efficacy of embolization of jaw arteriovenous malformations: one center observational ... | jaw arteriovenous malformations | group of bleeding:coils and absolute ethanol;group of no bleeding:coils and absolute ethanol; | Shanghai Ninth People Hospital, School of Medicine, Shanghai Jiaotong University | NULL | Pending | 5 | 15 | Both | group of bleeding:30;group of no bleeding:30; | N/A | China |
6 | ChiCTR2000036576 | 2020-09-01 | 2020-08-24 | A randomized controlled trial for comparing the effect and outcomes with different embolic agent: Absolute Ethanol and Onyx in the treatment of AVM A randomized controlled trial for comparing the effect and outcomes with different embolic agent: Ab ... | A randomized controlled trial for comparing the effect and outcomes with different embolic agent: Absolute Ethanol and Onyx in the treatment of AVM A randomized controlled trial for comparing the effect and outcomes with different embolic agent: Ab ... | arteriovenous malformations | Group 1:absolute ethanol;Group 2:Oynx; | Shanghai Ninth People Hospital, School of Medicine, Shanghai Jiaotong University | NULL | Recruiting | Both | Group 1:30;Group 2:30; | N/A | China | ||
7 | NCT04999618 (ClinicalTrials.gov) | January 1, 2020 | 17/7/2021 | A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular ... | DOUBLE-SKIN: a New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology: a Randomised, Double-blind, Placebo-controlled Trial DOUBLE-SKIN: a New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed W ... | Vascular Diseases;Vascular Malformation;Capillary Malformation-Arteriovenous Malformation;Port-Wine Stain;Sturge-Weber Syndrome;Vascular Tumor Vascular Diseases;Vascular Malformation;Capillary Malformation-Arteriovenous Malformation;Port-Wine ... | Drug: Haemoblock;Other: Placebo | Center for Vascular Pathology, Moscow | NULL | Completed | 6 Months | 18 Years | All | 200 | Phase 4 | Russian Federation |
8 | EUCTR2019-001530-33-FR (EUCTR) | 29/06/2019 | 01/04/2019 | TOPical sirolimus in linGUal microkystic lymphatic malformation-TOPGUN | TOPical sirolimus in linGUal microkystic lymphatic malformation-TOPGUN - TOPGUN | Lingual microcystic lymphatic malformations (LMLM) in children and adults MedDRA version: 20.0;Level: LLT;Classification code 10003229;Term: Arteriovenous malformations;System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15] Lingual microcystic lymphatic malformations (LMLM) in children and adults MedDRA version: 20.0;Level ... | Trade Name: RAPAMUNE Product Name: Sirolimus 1mg/mL Product Code: L04AA10 | CHRU TOURS | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 12 | Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): no Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ... | France | ||
9 | ChiCTR1900021901 | 2019-03-20 | 2019-03-15 | Efficacy and Safety of Thalidomide for the Treatment of Arteriovenous Malformations in Central Nervous System: Pilot Study Efficacy and Safety of Thalidomide for the Treatment of Arteriovenous Malformations in Central Nervo ... | Efficacy and Safety of Thalidomide for the Treatment of Arteriovenous Malformations in Central Nervous System: Pilot Study Efficacy and Safety of Thalidomide for the Treatment of Arteriovenous Malformations in Central Nervo ... | central nervous system arteriovenous malformations | Case series:Oral thalidomide; | Xuanwu Hospital, Capital Medical University | NULL | Completed | Both | Case series:30; | China | |||
10 | EUCTR2018-001359-11-FR (EUCTR) | 22/02/2019 | 23/07/2018 | 0.1% topical sirolimus in the treatment of cutaneous microcystic lymphatic malformations in children and adults: phase II, split-body randomized, double-blind, vehicle-controlled clinical trial 0.1% topical sirolimus in the treatment of cutaneous microcystic lymphatic malformations in children ... | 0.1% topical sirolimus in the treatment of cutaneous microcystic lymphatic malformations in children and adults: phase II, split-body randomized, double-blind, vehicle-controlled clinical trial - TOPICAL 0.1% topical sirolimus in the treatment of cutaneous microcystic lymphatic malformations in children ... | Cutaneous microcystic lymphatic malformations (CMLM) in children and adults MedDRA version: 20.0;Level: LLT;Classification code 10003229;Term: Arteriovenous malformations;System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15] Cutaneous microcystic lymphatic malformations (CMLM) in children and adults MedDRA version: 20.0;Lev ... | Product Name: Sirolimus 0,1% crème INN or Proposed INN: SIROLIMUS | CHRU TOURS | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | 55 | Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): no Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ... | France |